Learn More
VX-984, MedChemExpress
MedChemExpress VX-984 (M9831) is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research.
Brand: Medchem Express HY-19939S
Description
VX-984 (M9831) is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research.Specifications
VX-984 | |
50 mg | |
Research | |
M9831 | |
O=C(C1=CC=NC2=C([C@H](C)CNC3=CC(C4=C([2H])N=C(C)N=C4[2H])=NC=N3)C=CC=C12)NC | |
415.49 | |
Research | |
Solid |
1476074-39-1 | |
White | |
C23H21D2N7O | |
DMSO : 10 mg/mL (24.07 mM; Need ultrasonic) | |
415.49 | |
98.34% | |
Cancer-Kinase/protease |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Research purposes only